Peter MacCallum Cancer Centre

Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci (2022) Devries AA, Dennis J, Tyrer JP, Peng PC, Coetzee SG, Reyes AL, Plummer JT, et al. Journal article MYB orchestrates T cell exhaustion and response to checkpoint inhibition (2022) Tsui C, Kretschmer L, Rapelius S, Gabriel SS, Chisanga D, Knoepper K, Utzschneider DT, et al. Journal article Incorporating progesterone receptor expression into the PREDICT breast prognostic model (2022) Grootes I, Keeman R, Blows FM, Milne RL, Giles GG, Swerdlow AJ, Fasching PA, et al. Journal article Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes (2022) Mavaddat N, Dorling L, Carvalho S, Allen J, Gonzalez-Neira A, Keeman R, Bolla MK, et al. Journal article Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes. (2022) Meagher NS, Gorringe KL, Wakefield MJ, Bolithon A, Pang CNI, Chiu DS, Anglesio MS, et al. Journal article Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study (2022) Girard N, Bar J, Garrido P, Garassino MC, McDonald F, Mornex F, Filippi AR, et al. Journal article Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition — A Descriptive Observational Retrospective Multicenter Analysis (2021) Zaremba A, Kramer R, De Temple V, Bertram S, Salzmann M, Gesierich A, Reinhardt L, et al. Journal article Survey of Challenges in Access to Diagnostics and Treatment for Neuroendocrine Tumor (NET) Patients (SCAN): PRRT in the Treatment of Neuroendocrine Tumor (NET) Patients (2021) Dureja S, Kolarova T, Mcdonnell M, Van Genechten D, Bouvier C, Gellerman E, O'Toole D, et al. Conference contribution Pattern of invasion in stage I mucinous ovarian cancer is prognostic within 2-years of diagnosis (2021) Meagher N, Koebel M, Anderson L, Tan A, Bolithon A, Anglesio M, Cohen P, et al. Conference contribution Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer (2021) Quinn MC, McCue K, Shi W, Johnatty SE, Beesley J, Civitarese A, O'Mara TA, et al. Journal article